BPA-nicholas LEE-37/5040-BIO RAD-CFX connect real-time PCR detection system-catalog#: 1855201
Ended Awarded Last action
- Contract number
- HHSN26100014
- Awardee
-
Bio-Rad Laboratories, Inc. UEI SSHPDYFGN7J9 Part of Bio-Rad Laboratories, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,985
Award facts
- Contract value 100% obligated
- $17,985.10 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Sunnyvale, CA 94086, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$10 | |
| Original award | $17,995 |
About this award
The National Cancer Institute awarded Bio-Rad Laboratories, Inc. a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $17,985.10 for a CFX Connect Real-Time PCR Detection System (Catalog #1855201) on June 30, 2014, with an ultimate completion date of July 24, 2014. The contract, which was performed in Sunnyvale, California, was awarded without a small business set-aside designation. This procurement falls under the Life Science Group Division of Bio-Rad Laboratories and represents a specialized instrumentation purchase supporting the Institute's research capabilities.
Real-time polymerase chain reaction (PCR) systems are essential molecular biology tools used in research settings to detect and quantify targeted DNA sequences in real-time during amplification. The CFX Connect platform is widely utilized in cancer research, genomics studies, and diagnostic development for applications including gene expression analysis, copy number variation detection, and quality control in laboratory environments. Bio-Rad's established position as a federal supplier of advanced scientific instrumentation, demonstrated through its extensive contract history with the National Institutes of Health, Centers for Disease Control and Prevention, and other federal agencies, made the company well-positioned to deliver this critical equipment to support the National Cancer Institute's research mission.
Quick answers
Who was awarded contract HHSN26100014?
HHSN26100014 was awarded to Bio-Rad Laboratories, Inc. by National Cancer Institute (National Institutes of Health) on June 30, 2014.
How much is contract HHSN26100014 worth?
The government has obligated $17,985 on HHSN26100014.
Is contract HHSN26100014 an order under another contract?
Yes. HHSN26100014 is a BPA call under HHSN263199800049653B, a blanket purchase agreement.
Was contract HHSN26100014 competed?
The extent of competition for HHSN26100014 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award